The company's poor financial performance and declining reven...
The company's poor financial performance and declining revenue may be causing its low P/S ratio and share price. The trend is expected to continue, affecting the share price further. Its revenue growth is lagging behind the industry, contributing to the low P/S ratio. The share price may continue to suffer unless conditions improve.
China NT Pharma Group Company Limited (HKG:1011) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment